COVID-19 and oral cavity - repercussions and post-vaccination care: a clinical case
DOI:
https://doi.org/10.33448/rsd-v11i5.27608Keywords:
COVID-19; Vaccine; Anticoagulants; Thrombocytopenia.Abstract
Adverse event descriptions such as rare thromboses with concomitant thrombocytopenia, including venous thromboses at unusual sites such as cerebral venous sinus thrombosis (CVST), intestinal venous and arterial thromboses, have been reported following vaccination for COVID-19 based on recombinant adenoviral vector. The emergence of clinical features of moderate to severe thrombocytopenia and thrombotic complications, increasing fibrin formation in different parts of the body, approximately 1 to 2 weeks after vaccination against SARS-CoV-2 suggests a disorder that clinically resembles clinical presentations of long-term use of heparin. The case report consists of paroxysmal left-sided hemicrania after local vaccination protocol, in addition, the patient presents areas of retraction and papillary necrosis, hyperplastic regions with bleeding, not consistent with periodontal diseases associated with biofilm, during the physical examination. The possibility of ischemic stroke in vaccinated people as well as in patients with COVID-19 justifies the therapeutic and prophylactic use of anticoagulants, increasing post-vaccination safety. Although the phenomena related to thromboembolic complications induced by the vaccine for COVID-19 are rare, a careful evaluation including specific laboratory tests and a correct systemic diagnosis is necessary. In addition, the observation of certain pathologies caused by thrombus formation in the oral cavity can help in the preventive identification of vaccine-induced thrombotic thrombocytopenia (VITT).
References
Baeder, F. M. ., Albuquerque, A. C. L. de, Corazza, P. F. L. ., Weigert, K. . L., Puricelli, E., Pasetti, L. A., Ferreira, A. M., Serrão, M. do C. P. N. ., Cardoso, A. M. R. ., Brito Filho, M. T. de ., Teodósio, G. C., Bomfim, M. A. C., Sobrinho, A. C. P. ., Forghieri, A. A., & Silva, D. F. . (2021). Oral lesions in patients infected with SARS-CoV-2: a case series . Research, Society and Development, 10(4), e45410414349. https://doi.org/10.33448/rsd-v10i4.14349
Baeder, F. M. ., Cardoso, A. M. R. ., Silva, D. F. ., Bomfim, M. A. C., Corazza, P. F. L. ., Pasetti, L. A., Albuquerque, A. C. L. de, Gomes, T. P., Araújo, A. K. R. C., Ramos, A. E. ., Brito, B. da S., Teodósio, G. C., Brito Filho, M. T. de ., Sobrinho, A. C. P. ., & Serrão, M. do C. P. N. . (2021). Evaluation of the oral hygiene of patients with COVID-19 in a hospital environment. Research, Society and Development, 10(7), e15810716272. https://doi.org/10.33448/rsd-v10i7.16272
Cho, Y. D., Kim, K. H., Lee, Y. M., Ku, Y., & Seol, Y. J. (2021). Periodontal Wound Healing and Tissue Regeneration: A Narrative Review. Pharmaceuticals (Basel, Switzerland), 14(5), 456. https://doi.org/10.3390/ph14050456
Corica, B., Cacciani, A., Cangemi, R., Visentini, M., Recchia, F., Grillo, R., Vano, M., Sperduti, N., Cincione, A., Buoninfante, G., Pulcinelli, F., Chistolini, A., De Santis, A., Flego, D., Romiti, G. F., Basili, S., & Stefanini, L. (2021). Clinical course, management, and platelet activity assessment of splanchnic VITT: A case report. Thrombosis research, 208, 14–17. https://doi.org/10.1016/j.thromres.2021.10.008
Dotan, A., & Shoenfeld, Y. (2021). Perspectives on vaccine induced thrombotic thrombocytopenia. Journal of autoimmunity, 121, 102663. https://doi.org/10.1016/j.jaut.2021.102663
Fu, J., Kong, J., Wang, W., Wu, M., Yao, L., Wang, Z., Jin, J., Wu, D., & Yu, X. (2020). The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China. Thrombosis research, 192, 3–8. https://doi.org/10.1016/j.thromres.2020.05.006
Greinacher, A., Thiele, T., Warkentin, T. E., Weisser, K., Kyrle, P. A., & Eichinger, S. (2021). Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination. The New England journal of medicine, 384(22), 2092–2101. https://doi.org/10.1056/NEJMoa2104840
Gürtler, L., Seitz, R., & Schramm, W. (2021). Cerebral venous thrombosis after COVID-19 vaccination: is the risk of thrombosis increased by intravascular application of the vaccine?. Infection, 49(5), 1071–1074. https://doi.org/10.1007/s15010-021-01658-x
Lavin, M., Elder, P. T., O'Keeffe, D., Enright, H., Ryan, E., Kelly, A., El Hassadi, E., McNicholl, F. P., Benson, G., Le, G. N., Byrne, M., Ryan, K., O'Connell, N. M., & O'Donnell, J. S. (2021). Vaccine-induced immune thrombotic thrombocytopenia (VITT) - a novel clinico-pathological entity with heterogeneous clinical presentations. British journal of haematology, 195(1), 76–84. https://doi.org/10.1111/bjh.17613
Li, Y., Zhao, K., Wei, H., Chen, W., Wang, W., Jia, L., Liu, Q., Zhang, J., Shan, T., Peng, Z., Liu, Y., & Yan, X. (2020). Dynamic relationship between D-dimer and COVID-19 severity. British journal of haematology, 190(1), e24–e27. https://doi.org/10.1111/bjh.16811
McGonagle, D., De Marco, G., & Bridgewood, C. (2021). Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection. Journal of autoimmunity, 121, 102662. https://doi.org/10.1016/j.jaut.2021.102662
Moreno, G., Carbonell, R., Bodí, M., & Rodríguez, A. (2021). Systematic review of the prognostic utility of D-dimer, disseminated intravascular coagulation, and anticoagulant therapy in COVID-19 critically ill patients. Revisión sistemática sobre la utilidad pronóstica del dímero-D, coagulación intravascular diseminada y tratamiento anticoagulante en pacientes graves con COVID-19. Medicina intensiva, 45(1), 42–55. https://doi.org/10.1016/j.medin.2020.06.006
Nikoloudaki, G., Creber, K., & Hamilton, D. W. (2020). Wound healing and fibrosis: a contrasting role for periostin in skin and the oral mucosa. American journal of physiology. Cell physiology, 318(6), C1065–C1077. https://doi.org/10.1152/ajpcell.00035.2020
Papapanou, P. N., Sanz, M., Buduneli, N., Dietrich, T., Feres, M., Fine, D. H., Flemmig, T. F., Garcia, R., Giannobile, W. V., Graziani, F., Greenwell, H., Herrera, D., Kao, R. T., Kebschull, M., Kinane, D. F., Kirkwood, K. L., Kocher, T., Kornman, K. S., Kumar, P. S., Loos, B. G., … Tonetti, M. S. (2018). Periodontitis: Consensus report of workgroup 2 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. Journal of periodontology, 89 Suppl 1, S173–S182. https://doi.org/10.1002/JPER.17-0721
Payares-Herrera, C., Martínez-Muñoz, M. E., Vallhonrat, I. L., de Molina, R. M., Torres, M. P., Trisan, A., de Diego, I. S., Alonso, R., Zafra, R., Donaire, T., Sánchez, R., Rubio, J. J., Duarte Palomino, R. F., & Solá, C. A. (2021). Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial. Trials, 22(1), 9. https://doi.org/10.1186/s13063-020-04964-1
Pereira, A. S., Shitsuka, D. M., Parreira, F. J., & Shitsuka, R. (2018). Metodologia da pesquisa cientifica. [free e-book]. Santa Maria: UAB/NTE/UFSM.
Pitones-Rubio, V., Chávez-Cortez, E. G., Hurtado-Camarena, A., González-Rascón, A., & Serafín-Higuera, N. (2020). Is periodontal disease a risk factor for severe COVID-19 illness?. Medical hypotheses, 144, 109969. https://doi.org/10.1016/j.mehy.2020.109969
Rostami, M., & Mansouritorghabeh, H. (2020). D-dimer level in COVID-19 infection: a systematic review. Expert review of hematology, 13(11), 1265–1275. https://doi.org/10.1080/17474086.2020.1831383
de Simone, G., Stranges, S., & Gentile, I. (2021). Incidence of cerebral venous thrombosis and COVID-19 vaccination: possible causal effect or just chance?. European heart journal. Cardiovascular pharmacotherapy, 7(4), e77–e78. https://doi.org/10.1093/ehjcvp/pvab036
Terpos, E., Ntanasis-Stathopoulos, I., Elalamy, I., Kastritis, E., Sergentanis, T. N., Politou, M., Psaltopoulou, T., Gerotziafas, G., & Dimopoulos, M. A. (2020). Hematological findings and complications of COVID-19. American journal of hematology, 95(7), 834–847. https://doi.org/10.1002/ajh.25829
Weber, C., von Hundelshausen, P., & Siess, W. (2021). VITT after ChAdOx1 nCoV-19 Vaccination. The New England journal of medicine, 385(23), 2203–2204. https://doi.org/10.1056/NEJMc2111026
Xiong, W., Mu, J., Guo, J., Lu, L., Liu, D., Luo, J., Li, N., Liu, J., Yang, D., Gao, H., Zhang, Y., Lin, M., Shen, S., Zhang, H., Chen, L., Wang, G., Luo, F., Li, W., Chen, S., He, L., … Zhou, D. (2020). New onset neurologic events in people with COVID-19 in 3 regions in China. Neurology, 95(11), e1479–e1487. https://doi.org/10.1212/WNL.0000000000010034
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Fernando Martins Baeder; Lilian Aparecida Pasetti; Paola Fernanda Leal Corazza; Daniel Furtado Silva; Ana Carolina Lyra de Albuquerque; Dênis Clay Lopes dos Santos; Antônio Francisco David; Andreia Medeiros Rodrigues Cardoso; Maria do Carmo Pessoa Nogueira Serrão
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
